R-evoWW took part to the Eleventh EDCTP Forum in the Palais des Congrès de Paris in Paris (France) from 7th to 10th November 2023.
This Forum marked EDCTP’s 20th Anniversary and the theme was “Partnering for Global Health Research Innovation and Impact in Africa – Celebrating EDCTP: two decades and beyond”.
Tuberculosis (TB) remains one of the leading infectious diseases worldwide. According to the WHO Global Tuberculosis Report, in 2023 an estimated 10.8 million people developed TB globally, and about 1.25
R-Evolution WorldWide, has recently submitted the project proposal IMPROVE-HIV under the European & Developing Countries Clinical Trials Partnership (EDCTP) call HORIZON-JU-GH-EDCTP3-2026-01-HIV-03-two-stage – Global collaboration action towards better prevention, treatment and clinical management
Respiratory infections remain one of the main causes of illness and death among newborns in sub-Saharan Africa. Respiratory Syncytial Virus (RSV) is a major contributor to severe disease in the